Brief: Wai Chun Bio Technology Entered Into Subscription Agreement With Chinese Success
22/10/2021 16:02
Oct 22 (Reuters) - Wai Chun Bio Technology Ltd 0660.HK :
* WAI CHUN BIO TECHNOLOGY LTD - ENTERED INTO SUBSCRIPTION
AGREEMENT WITH CHINESE SUCCESS
* WAI CHUN BIO TECHNOLOGY LTD - CONDITIONALLY AGREED TO
ISSUE NEW
CONVERTIBLE BONDS IN PRINCIPAL AMOUNT OF HK$21 MILLION
* WAI CHUN BIO TECHNOLOGY - CONVERSION PRICE OF HK$0.05 PER
NEW
CONVERTIBLE BONDS CONVERSION SHARE
Further company coverage: 0660.HK
(Reuters.briefs@thomsonreuters.com)
Recent news on Wai Chun Bio Technology
See all newsBrief: Wai Chun Bio Technology Says Unable To Publish FY2026 Annual Results By Sept 30
Brief: Wai Chun Bio Technology Enters MoU For Ai Digital Infrastructure Project In Malaysia
Brief: Wai Chun Bio Technology Appointed Exclusive Overseas Master Agent For Crane And Mining Equipment Globally
Brief: Wai Chun Bio Technology Signs MoU For Strategic Cooperation On New Energy Projects
Brief: Wai Chun Bio Technology Receives Judgment From Hong Kong High Court Against Co, Wai Chun Group